Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AVEO Pharmaceuticals Inc (AVEO)

  7. AVEO Pharmaceuticals Inc (AVEO) Financials

AVEO

AVEO Pharmaceuticals Inc

15.00
0.00 (0.0%)
Upgrade to Real-Time

AVEO Pharmaceuticals Inc. (AVEO) Fundamentals
AVEO Pharmaceuticals Inc is a commercial-stage, oncology-focused biopharmaceutical company engaged in offering medicines that provide a better life for patients with cancer. The company markets FOTIVDA (tivozanib) in the United States.
SHARE INFORMATION
Market Cap$ 521,446,905
Shares Outstanding34,763,127
Float34,654,167
Percent Float99.69%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 42,295,000
Latest Fiscal EPS$ -1.70
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions162
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months1,505,618
Institutional Holdings Percent68.5%
Institutional Sold Previous 3 Months1,792,795
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months32,325,483
Insider Holdings Percent7.3
Insider Sold Previous 3 Months67,892,073
Insider Shares Owned2,521,894
TRADING INFO
52 Week High$ 15.00
52 Week Low$ 3.06
52 Week High Change$ 376.19
21 Day Moving Average$ 14.9695
21 Day Extended Moving Average$ 14.9643
50 Day Moving Average$ 14.9258
50 Day Extended Moving Average$ 14.5286
200 Day Moving Average$ 9.4655
200 Day Extended Moving Average$ 10.8012
10 Day Average Volume212,065
20 Day Average Volume406,106
30 Day Average Volume379,343
50 Day Average Volume393,054
Alpha0.012735
Beta1.0029
Standard Deviation0.262937
R20.042302
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.07
21 Day Percent Change0.47%
30 Day Price Change$ 0.03
30 Day Percent Change0.2%
Month to Date Price Change$ 0.05
Month to Date Percent Change0.33%
Quarter to Date Price Change$ 0.05
Quarter to Date Percent Change0.33%
180 Day Price Change$ 7.99
180 Day Percent Change113.98%
200 Day Price Change$ 8.19
200 Day Percent Change120.26%
Year to Date Price Change$ 0.05
Year to Date Percent Change0.33%

AVEO Pharmaceuticals Inc. (AVEO) Key Ratios

PROFITABILITY
EBIT Margin-25.9%
EBITDA Margin-25.8%
Pre-Tax Profit Margin-311.0%
Profit Margin Count-28.41%
Gross Margin87.8%
Profit Margin TOT-28.41%
INCOME STATEMENTS
Revenue$ 76,673,000
Revenue Per Share$ 2.2056
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book18.10
Total Debt To Equity1.30
Int Coverage-5.30
Current Ratio3.30
Leverage Ratio3.10
Quick Ratio2.30
Long Term Debt To Capital0.57
VALUATION MEASURES
PE Ratio-18.30
Enterprise Value$ 482,728,905
Price to Sales6.8009
Price to Free Cash-49.80
PE High Last 5 Years-6.10
Price To Book18.10
Price To Cash Flow0.00
PE Low Last 5 Years-20.30
Price to Tangible Book18.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.20
Invoice Turnover9.10
Assets Turnover0.80
Return Assets-29.99
Return on Equity-80.39
Return on Capital-32.12

AVEO Pharmaceuticals Inc. (AVEO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOMichael P. Bailey
Employees115
Last AuditUQ
CIK0001325879
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address30 Winter Street
14th Floor
Boston, MA 2108
Websitehttps://www.aveooncology.com
Facsimile+1 617 621-1406
Telephone+1 857 400-0101
Emailaveo@argotpartners.com


Your Recent History
NASDAQ
AVEO
AVEO Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.